Learning from the pandemic: Birmingham Health Partners publishes rapid evaluation study of remote outpatient appointments
Birmingham Health Partners (BHP), the second city’s University-NHS partnership, has called for greater engagement with clinicians and a deeper understanding of patient experience when considering t…
New drug can lower brain pressure and treat blinding IIH headaches, finds trial
Patients with Idiopathic Intercranial Hypertension (IIH) – a condition which causes raised brain pressure and debilitating headaches – could be treated with an injectable peptide used for type 2 di…
Funding boost for Birmingham rare disease research
BHP founder-member the University of Birmingham has been awarded a £500k Pathfinder Award from the medical research charity LifeArc which will support early-stage projects with a focus on translati…
BHP invests £300k in innovative service improvement projects
Birmingham Health Partners (BHP), the second city’s University-NHS partnership, has announced the inaugural recipients of its Seed Fund programme, awarding more than £300,000 to four projects acros…
Review of 25 years reveals AI healthtech is beginning to listen to patients
Patients experiences of their health conditions are slowly being integrated into AI studies, a review of 25 years of healthcare publications has found.
Published in the Lancet Digital Health, th…
Leukaemia trial tests Covid vaccine strategies to combat immune suppression
Patients with the most common form of leukaemia – Chronic Lymphocytic Leukaemia (CLL) – are being invited to take part in a trial that could help them build Covid-19 antibodies following vaccinatio…